Nu Skin Enterprises (NUS)
(Real Time Quote from BATS)
$6.78 USD
-0.15 (-2.17%)
Updated Sep 25, 2024 09:50 AM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
NUS 6.78 -0.15(-2.17%)
Will NUS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NUS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NUS
Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?
NUS Stock Hurt by Customer Acquisition Challenges: How to Play Ahead?
NUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
Are Options Traders Betting on a Big Move in Nu Skin (NUS) Stock?
Nu Skin (NUS) Trims FY24 View Despite Q2 Earnings Beat
Other News for NUS
Multi-Level Marketing: Stagnation Or Something Worse?
Nu Skin Enterprises Appoints Mark A. Zorko to Board of Directors
Nu Skin Expands Board with Mark Zorko’s Appointment
Nu Skin names Mark Zorko to board of directors
CNH Industrial, Parsons and more join S&P MidCap 400